LeonaBio (LONA) Convertible Debt (2019)
LeonaBio (LONA) posted quarterly Convertible Debt of $1.6 million for Q4 2019.
LeonaBio (LONA) Convertible Debt (2019) Analysis & Trends
LeonaBio (LONA) has reported Convertible Debt for 1 consecutive years, with $1.6 million the latest figure, recorded in Q4 2019.
- In Q4 2019, Convertible Debt changed N/A year-over-year to $1.6 million; the TTM figure through Dec 2019 stood at $1.6 million (changed N/A YoY), while the FY2019 annual figure was $1.6 million, changed N/A from the prior year.
- Convertible Debt steadied at $1.6 million in Q4 2019 per LONA's latest filing.
- Across five years, Convertible Debt topped out at $1.6 million in Q4 2019 and bottomed at $1.6 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | LeonaBio | 180.91 Mn | 129.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 1.55 Mn |